Evaluation of Nimustine Hydrochloride/Etoposide Combination Chemotherapy for Malignant Gliomas. Part 2. Clinical Significance as an Adjuvant Chemotherapy.
2) DAVIS FG. Survival rates in patients with primary malignant brain tumors stratified by patients age and tumor histological type:An analysis based on surveillance, epidemiology, and end results (SEER) data, 1973-1991. J Neurosurg. (1998) vol.88, p.1-10.
3) DINAPOLI RP. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.. J Clin Oncol. (1993) vol.11, p.1316-1321.
4) HILDEBRAN J. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. Neurology. (1994) vol.44, p.1479-1483.